semaglutide/glycine/b12 dosing semaglutide glycine b12 Maximum Semaglutide Dosing: Exploring Benefits and Risks Syringes and Dosing | Jeffrey

Risk factors that may prompt additional consideration include: Active gastrointestinal symptoms (nausea, vomiting, abdominal pain) Recent dose increases or being in the dose-escalation phase Higher doses of semaglutide Known gastroparesis or other conditions affecting gastric emptying Obesity with GERD or hiatal hernia Based on the 2024 multi-society guidance, most patients can continue GLP-1 receptor agonists before elective procedures with appropriate risk assessment and mitigation strategies, rather than automatic postponement

Discuss fertility plans with your GP or specialist to ensure safe discontinuation timing and appropriate contraception whilst on treatment

Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jdar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, et al

Other GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists may be considered in some care plans